Clinical data | |
---|---|
Trade names | Differin, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a604001 |
License data | |
Pregnancy category |
|
Routes of administration | Topical |
Drug class | Retinoids |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | Very low[medical citation needed] |
Excretion | Bile duct |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.149.379 |
Chemical and physical data | |
Formula | C28H28O3 |
Molar mass | 412.529 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Adapalene is a third-generation topical retinoid primarily used in the treatment of mild-moderate acne, and is also used off-label to treat keratosis pilaris as well as other skin conditions.[6] Studies have found adapalene is as effective as other retinoids, while causing less irritation.[7] It also has several advantages over other retinoids. The adapalene molecule is more stable compared to tretinoin and tazarotene, which leads to less concern for photodegradation.[7] It is also chemically more stable compared to the other two retinoids, allowing it to be used in combination with benzoyl peroxide.[7] Due to its effects on keratinocyte proliferation and differentiation, adapalene is superior to tretinoin for the treatment of comedonal acne and is often used as a first-line agent.[8] The Swiss company Galderma sells adapalene under the brand name Differin.